Evidence map›Paper›PMID 35845090›Full record

ReviewJournal of inflammation research2022

Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis.

Xingyu Chang, Yuchen Kang, Yuxuan Yang, Yajie Chen, Yanyu Shen, Chenjun Jiang, Yi Shen

Open access · goldAbstract readReview
In one paragraph

Review in Journal of inflammation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Battling pain from osteoarthritis: causing novel cell death.Acta biochimica et biophysica Sinica · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xingyu Chang *The First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.ORCID 0000-0002-7403-1956
Yuchen Kang *The Second Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Yuxuan Yang *The First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Yajie ChenThe First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Yanyu ShenThe First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Chenjun JiangThe First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Yi ShenDepartment of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China.
Lanzhou University · CNCentral South University · CNLanzhou University Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is one of the most common chronic joint diseases and is gradually becoming the main cause of disability and joint pain in the elderly worldwide. Pyroptosis is a regulated programmed cell death triggered by inflammasomes. It leads to cell swelling, lysis, and bioactive molecule secretion. Studies found that the damaged chondrocytes in OA joints had morphological characteristics of pyroptosis, and the cytokines associated with pyroptosis in synovial fluid increased, indicating that pyroptosis may have certain impacts on the pathological progression of OA. This review briefly summarizes the molecular mechanisms of pyroptosis and the epidemiology and pathogenesis of OA. Furthermore, we discussed the role of pyroptosis in articular cartilage and synovium during OA and reviewed the progress of pyroptosis-related molecules in the targeted therapy of OA joints, hoping to provide feasible directions for the diversified treatment of OA.

Indexed as

articular cartilageGSDMDNLRP3 inflammasomeosteoarthritispyroptosissynovium

Identifiers

PMID35845090
PMCPMC9285853
OpenAlexW4285008546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.